FIELD: medicine.
SUBSTANCE: invention refers to methods for adsorption of an active agent representing protein or peptide, on a surface in a pre-formed crystalline diketopiperasine microparticles which includes the stage: modifying of chemical potential of the active agent which provides energy-favourable reaction of the active agent and the diketopiperasine microparticle and does not include solvent removal, and the stage of adsorption of the active agent on a surface of the pre-formed crystalline diketopiperasine microparticle. The modifying stage of chemical potential includes change of the solution medium by adding a modifier of the active agent to the solution.
EFFECT: higher adsorption of the active agent on the surfaces of the microparticle with reduced tendency to remain in the solution.
31 cl, 17 dwg, 7 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITIONS, CONTAINING GLUCAGON-LIKE PEPTIDE (GLP-1) | 2007 |
|
RU2409349C2 |
PHARMACEUTICAL COMPOSITIONS, CONTAINING GLUCAGON-LIKE PEPTIDE 1 (GLP-1) | 2007 |
|
RU2542500C2 |
METHOD FOR PREPARING DRUG COMPOSITION BASED ON INCREASING ACTIVE AGENT AFFINITY OF CRYSTALLINE MICROPARTICLE SURFACES | 2010 |
|
RU2443414C2 |
METHOD OF OBTAINING MEDICAL COMPOSITION, BASED ON INCREASE OF CRYSTAL MICRO PARTICLES SURFACE AFFINITY TO ACTIVE AGENTS | 2006 |
|
RU2394550C2 |
METHOD FOR PREVENTING GLP-1 SIDE EFFECTS | 2008 |
|
RU2474415C2 |
ACTIVE SUBSTANCE DELIVERY | 2008 |
|
RU2467741C2 |
DIKETOPIPERAZINE MICROPARTICLES WITH PARTICULAR SPECIFIC SURFACE AREAS | 2010 |
|
RU2509555C2 |
DIKETOPIPERAZIN MICROPARTICLES WITH PARTICULAR AMOUNT OF ISOMERS | 2010 |
|
RU2490026C1 |
METHOD OF IMPROVING PHARMACEUTICAL PROPERTIES OF PARTICLES, CONTAINING DIKETOPIPERAZINE AND ACTIVE AGENT | 2007 |
|
RU2403059C2 |
DRY POWDER DRUG DELIVERY SYSTEMS AND METHODS | 2013 |
|
RU2650035C2 |
Authors
Dates
2010-05-27—Published
2006-09-14—Filed